John V. Soden

Managing Director

(415) 962-2922

Cain Brothers Experience

John Soden co-leads Cain Brothers’ Medical Technologies Advisory practice based in San Francisco. His practice has focused on medical devices, diagnostics and life science tools/reagents since 2001, prior to which he specialized in M&A and worked across multiple industries.

Mr. Soden joined Cain Brothers in early 2016 with over 20 years of investment banking experience, primarily focused on private and public company M&A.  Recent advisory transactions include the sale of SeraCare Life Sciences (owned by Linden) to LGC (owned by KKR), California Cryobank’s sale to GI Partners and its simultaneous merger with Cord Blood Registry, Patricia Industries’ acquisition of Sarnova from Water Street, 3i Group’s acquisition of Cirtec Medical, Frazier’s merger of PREZIO and Northfield, and the sale of Clinical Innovations by The Pritzker Group to EQT Partners. Recent leveraged finance experience includes serving as left lead arranger/joint bookrunner/administrative agent for Linden’s $325mm acquisition financing of Avalign Technologies and as joint bookrunner/joint lead arranger for THL’s SPAC’s $810mm acquisition financing of UHS (renamed Agiliti Health).

Prior Experience

Previously, Mr. Soden was a Managing Director & Head of Medical Technologies at Houlihan Lokey for approximately seven years.  Mr. Soden’s transactions immediately prior to joining Cain Brothers included the sale of Hygiena to Warburg Pincus, Galil Medical to BTG Plc, CORPAK MedSystems (owned by Linden) to Halyard Health, Cord Blood Registry (owned by GTCR) to AMAG Pharmaceuticals, Ivera Medical to 3M, Integrated Medical Systems (IMS) to Steris, and Angiotech’s Interventional business to Argon Medical Devices (then owned by RoundTable Healthcare Partners).  Notable restructuring experience included creditor representations with respect to Ameritox and Angiotech Pharmaceuticals.

Before Houlihan Lokey, Mr. Soden worked for over six years in the Healthcare Group at Thomas Weisel Partners, most recently as a Managing Director, and for five years at UBS (and its predecessor Dillion, Read & Co.), eventually serving as a Director in both the M&A and Healthcare groups. He began his investment banking career as a financial analyst at CS First Boston in 1994.


Mr. Soden received a B.A. in Economics (with Honors) from Northwestern University.